ID

17201

Beschreibung

Efficacy and Safety of Vildagliptin in Combination With Glimepiride in Patients With Type 2 Diabetes; ODM derived from: https://clinicaltrials.gov/show/NCT00099944

Link

https://clinicaltrials.gov/show/NCT00099944

Stichworte

  1. 31.08.16 31.08.16 -
Hochgeladen am

31. August 2016

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY 4.0

Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Itemgroup Kommentare für :

Item Kommentare für :

Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

Eligibility Diabetes Mellitus, Type 2 NCT00099944

Eligibility Diabetes Mellitus, Type 2 NCT00099944

Inclusion Criteria
Beschreibung

Inclusion Criteria

Alias
UMLS CUI
C1512693
blood glucose criteria must be met
Beschreibung

Blood Glucose criteria Fulfill

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0005802
UMLS CUI [1,2]
C0243161
UMLS CUI [1,3]
C1550543
previously treated with a sulfonylurea for at least 3 months
Beschreibung

Sulfonylurea

Datentyp

boolean

Alias
UMLS CUI [1]
C0038766
body mass index (bmi) in the range 22-45
Beschreibung

Body mass index

Datentyp

boolean

Alias
UMLS CUI [1]
C1305855
Exclusion Criteria
Beschreibung

Exclusion Criteria

Alias
UMLS CUI
C0680251
type 1 diabetes
Beschreibung

Diabetes Mellitus, Insulin-Dependent

Datentyp

boolean

Alias
UMLS CUI [1]
C0011854
pregnancy or lactation
Beschreibung

Pregnancy | Breast Feeding

Datentyp

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
evidence of serious cardiovascular complications
Beschreibung

Cardiac complication Serious Evidence of

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0161816
UMLS CUI [1,2]
C0205404
UMLS CUI [1,3]
C0332120
evidence of serious diabetic complications
Beschreibung

Complications of Diabetes Mellitus Serious Evidence of

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0342257
UMLS CUI [1,2]
C0205404
UMLS CUI [1,3]
C0332120
laboratory value abnormalities as defined by the protocol
Beschreibung

Laboratory test result abnormal

Datentyp

boolean

Alias
UMLS CUI [1]
C0438215
known sensitivity to glimepiride
Beschreibung

Sensitivity glimepiride

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0020517
UMLS CUI [1,2]
C0061323
other protocol-defined exclusion criteria may apply
Beschreibung

Exclusion Criteria Study Protocol

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0680251
UMLS CUI [1,2]
C2348563

Ähnliche Modelle

Eligibility Diabetes Mellitus, Type 2 NCT00099944

Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
C1512693 (UMLS CUI)
Blood Glucose criteria Fulfill
Item
blood glucose criteria must be met
boolean
C0005802 (UMLS CUI [1,1])
C0243161 (UMLS CUI [1,2])
C1550543 (UMLS CUI [1,3])
Sulfonylurea
Item
previously treated with a sulfonylurea for at least 3 months
boolean
C0038766 (UMLS CUI [1])
Body mass index
Item
body mass index (bmi) in the range 22-45
boolean
C1305855 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Diabetes Mellitus, Insulin-Dependent
Item
type 1 diabetes
boolean
C0011854 (UMLS CUI [1])
Pregnancy | Breast Feeding
Item
pregnancy or lactation
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
Cardiac complication Serious Evidence of
Item
evidence of serious cardiovascular complications
boolean
C0161816 (UMLS CUI [1,1])
C0205404 (UMLS CUI [1,2])
C0332120 (UMLS CUI [1,3])
Complications of Diabetes Mellitus Serious Evidence of
Item
evidence of serious diabetic complications
boolean
C0342257 (UMLS CUI [1,1])
C0205404 (UMLS CUI [1,2])
C0332120 (UMLS CUI [1,3])
Laboratory test result abnormal
Item
laboratory value abnormalities as defined by the protocol
boolean
C0438215 (UMLS CUI [1])
Sensitivity glimepiride
Item
known sensitivity to glimepiride
boolean
C0020517 (UMLS CUI [1,1])
C0061323 (UMLS CUI [1,2])
Exclusion Criteria Study Protocol
Item
other protocol-defined exclusion criteria may apply
boolean
C0680251 (UMLS CUI [1,1])
C2348563 (UMLS CUI [1,2])

Benutzen Sie dieses Formular für Rückmeldungen, Fragen und Verbesserungsvorschläge.

Mit * gekennzeichnete Felder sind notwendig.

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video